The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
15-year survival outcomes following primary androgen deprivation therapy for localized prostate cancer.
Grace L. Lu-Yao
Employment or Leadership Position - Merck (I)
Consultant or Advisory Role - Merck
Stock Ownership - Merck (B)
Peter C. Albertsen
No relevant relationships to disclose
Dirk Moore
No relevant relationships to disclose
Weichung Shih
No relevant relationships to disclose
Yong Lin
No relevant relationships to disclose
Robert S. DiPaola
No relevant relationships to disclose
Siu-Long Yao
Employment or Leadership Position - Merck
Consultant or Advisory Role - Merck (I)
Stock Ownership - Merck (B)